Justin Jordan, M.D., M.P.H. Titles and Appointments Associate Professor Schools Medical School Departments Neurology | Peter O'Donnell Jr. Brain Institute You have reached the Academic Profile. For more information on the doctor and patient care, please visit the clinical profile. Biography Dr. Jordan is Associate Professor of Neurology with a secondary appointment in the Peter O’Donnell Jr. Brain Institute at the University of Texas Southwestern Medical Center in Dallas, Texas. He serves as Head of the Neuro-Oncology Section, where he treats patients with primary brain tumors and also runs a comprehensive clinic for adult patients affected by NF1 and schwannomatosis. Dr. Jordan also has a long history of conducting research related to NF1 and schwannomatosis, including work on interventional clinical trials for cutaneous neurofibromas, plexiform neurofibromas, and gliomas in NF1, all tumor types in NF2-related schwannomatosis, and chronic pain in non-NF2-related schwannomatosis. He has collaborated or led research investigations on novel imaging techniques including longitudinal whole body MRI scans, radiomics, and high-frequency ultrasound to advance our understanding of tumor behavior over time. He is a member of the Clinical Care Advisory Board of the Children's Tumor Foundation, and served as Chair of the Scientific Advisory Committee for Neurofibromatosis Network 2022-2025. Dr. Jordan is also deeply committed to promoting data-driven improvements in the healthcare landscape. He serves as Head of the Policy, Outreach, and Societal Transformation (POST) Section in the Department of Neurology, with focused work on health policy, community-based neurology care, and global neurology care. He is also Vice Chair of the Advocacy Committee and a Member of the Brain Health Committee within the American Academy of Neurology. Education Medical School McGovern Medical School at the University of Texas Health Science Center at Houston (2009) Residency Parkland Health & Hospital System (2013), Neurology Fellowship Harvard Medical School/Massachusetts General Hospital (2015), Neuro-oncology Research Interest Brain Tumors Glioblastoma IDH mutant gliomas Neurofibromatosis NF2-related schwannomatosis Schwannomatosis Publications A retrospective study of treatment and outcomes in synchronous systemic and central nervous system large B-cell lymphoma Haydu JE, Redd RA, Lei MM, Hochberg EP, Barnes JA, Armand P, Soumerai JD, Eichler AF, Jacobsen ED, Jordan JT, Jacobson CA, LaCasce AS, Arrillaga-Romany I, McFaline-Figueroa JR, Plotkin SR, Takvorian RW, Chukwueke UN, Crombie JL, Johnson PC, Karschnia P, Dietrich J, Nayak L, Abramson JS Blood Advances 2026 Jan 10 479-491 Clinical experience with tovorafenib in adults with treatment-refractory high- and low-grade gliomas Ioannou M, Mehta S, Devkota A, Bagley SJ, Ozer BH, Romo CG, Welch MR, Justin JT, Holdhoff M, Schreck KC Neuro-Oncology Practice 2025 Dec 12 1051-1057 A single-cell atlas of Schwannoma across genetic backgrounds and anatomic locations Gonzalez Castro LN, Gavish A, Bussema L, Mount CW, Neftel C, Nomura M, Chiocca EA, Bi WL, Arnaout O, Barker FG, Brown JM, Jordan JT, Batchelor TT, Stemmer-Rachamimov A, Plotkin SR, Tirosh I, Suvà ML Genome Medicine 2025 Dec 17 Self-reported access to specialty clinics and receipt of health surveillance among U.S. patients with neurofibromatosis 1: a national survey Merker VL, Ma Y, Chibnik LB, Radtke HB, Kelts K, Yohay K, Ullrich NJ, Plotkin SR, Jordan JT Orphanet Journal of Rare Diseases 2025 Dec 20 Increased Hemorrhage During Excision of Bevacizumab-Treated NF2-Related Vestibular Schwannomas Wood CG, Kozanno L, Stemmer-Rachamimov A, Lee DJ, Barker FG, Carter BS, Plotkin SR, Jordan JT, Chang LS, Welling DB Laryngoscope 2025 Nov 135 4355-4363 Principles for Novel Neurologic Therapeutics: An AAN Position Statement Goldstein LB, Crowe JR, Deb A, Jordan JT, Santoro JD, Sejvar JJ, Turbes M, Shapiro RE Neurology 2025 Jun 105 Bridging the Gap Between Brain Health Guidelines and Real-world Implementation Correa DJ, Jordan JT, Said RR CONTINUUM Lifelong Learning in Neurology 2025 Jun 31 865-884 ACR Appropriateness Criteria® Brain Tumors Author Collaboration EP, Ivanidze J, Shih RY, Utukuri PS, Ajam AA, Auron M, Chang SM, Jordan JT, Kalnins A, Kuo PH, Ledbetter LN, Pannell JS, Pollock JM, Sheehan J, Soares BP, Soderlund KA, Wang LL, Burns J Journal of the American College of Radiology 2025 May 22 S108-S135 AAN Position: Opioids Najib U, Cheng EM, Halker Singh RB, Ayub N, Nelson SE, Bushard PJ, Jordan JT, Sico JJ, Turbes M, Anderson WE Neurology 2025 Apr 104 Ivosidenib for the treatment of IDH1-mutant glioma, grades 2-4: Tolerability, predictors of response, and outcomes Lanman TA, Youssef G, Huang R, Rahman R, Desalvo M, Flood T, Hassanzadeh E, Lang M, Lauer J, Potter C, Jiao A, Pan I, Cahill DP, Lan Z, Ospina JP, Nakhate V, Stec NE, Shi D, Bi WL, McBrayer SK, Arrillaga-Romany I, Lee EQ, Chukwueke UN, Nayak L, Forst DA, Gerstner ER, Jordan JT, Dietrich J, Miller J, Batchelor TT, Reardon DA, Wen PY, Gonzalez Castro LN Neuro-Oncology Advances 2025 Jan 7 Results 1-10 of 102 1 2 3 4 5 Next Last Books Featured Books Neurology Self-Assessment: A Companion to Bradley's Neurology in Clinical Practice Justin T. Jordan, David R. Mayans, Michael Soileau (2016). Elsevier Evaluation of Peripheral Nerve Lesions. In Neuro-Oncology for the Clinical Neurologist Ly KI, Jordan JT (2021). Elsevier Neuro-Oncology. In Pocket Neurology, Third Edition Andersen B, Jordan JT (). Honors & Awards Make NF Visible Community Recognition Award NomineeChildren's Tumor Foundation (2024) Top Reviewer RewardNeurology: Education journal (2022) Patient Safety Stars AwardMassachusetts General Hospital (2021) Response Evaluation in Neurofibromatosis and Schwannomatosis (REiNS) ScholarREiNS (2016) Distinguished Alumnus LecturerUT Southwestern Medical Center, Department of Neurology (2015) Ether Dome Challenge AwardMass General Cancer Center Professional Associations/Affiliations American Academy of Neurology Children's Tumor Foundation Society for Neuro-Oncology
